NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,104 | -64.5% | 217 | -64.8% | 0.01% | -62.5% |
| Q2 2023 | $62,261 | +9.7% | 617 | 0.0% | 0.02% | +4.3% |
| Q1 2023 | $56,764 | -24.2% | 617 | -25.3% | 0.02% | -37.8% |
| Q4 2022 | $74,935 | +10.2% | 826 | -7.9% | 0.04% | +8.8% |
| Q3 2022 | $68,000 | -36.4% | 897 | -28.9% | 0.03% | -30.6% |
| Q2 2022 | $107,000 | -3.6% | 1,262 | 0.0% | 0.05% | +8.9% |
| Q1 2022 | $111,000 | -24.5% | 1,262 | -25.0% | 0.04% | -23.7% |
| Q4 2021 | $147,000 | +79.3% | 1,682 | +68.2% | 0.06% | +63.9% |
| Q3 2021 | $82,000 | -9.9% | 1,000 | 0.0% | 0.04% | -12.2% |
| Q2 2021 | $91,000 | +7.1% | 1,000 | 0.0% | 0.04% | -2.4% |
| Q1 2021 | $85,000 | -9.6% | 1,000 | 0.0% | 0.04% | -16.0% |
| Q4 2020 | $94,000 | +8.0% | 1,000 | 0.0% | 0.05% | -7.4% |
| Q3 2020 | $87,000 | 0.0% | 1,000 | 0.0% | 0.05% | -8.5% |
| Q2 2020 | $87,000 | +6.1% | 1,000 | 0.0% | 0.06% | +7.3% |
| Q1 2020 | $82,000 | – | 1,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |